166 related articles for article (PubMed ID: 15339855)
1. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index.
Marcucci C; Madjdpour C; Spahn DR
Br Med Bull; 2004; 70():15-28. PubMed ID: 15339855
[TBL] [Abstract][Full Text] [Related]
2. Risks, benefits, alternatives and indications of allogenic blood transfusions.
Madjdpour C; Heindl V; Spahn DR
Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusion in critically injured patients: a prospective study.
Beale E; Zhu J; Chan L; Shulman I; Harwood R; Demetriades D
Injury; 2006 May; 37(5):455-65. PubMed ID: 16476429
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia.
Jansen AJ; Caljouw MA; Hop WC; van Rhenen DJ; Schipperus MR
Transfus Med; 2004 Feb; 14(1):33-8. PubMed ID: 15043591
[TBL] [Abstract][Full Text] [Related]
5. Hb content-based transfusion policy successfully reduces the number of RBC units transfused.
Arslan O; Toprak S; Arat M; Kayalak Y
Transfusion; 2004 Apr; 44(4):485-8. PubMed ID: 15043562
[TBL] [Abstract][Full Text] [Related]
6. Transfusion in the cardiac patient.
Spahn DR; Dettori N; Kocian R; Chassot PG
Crit Care Clin; 2004 Apr; 20(2):269-79. PubMed ID: 15135465
[TBL] [Abstract][Full Text] [Related]
7. Perioperative Transfusion Triggers for Red Blood Cells.
Spahn DR
Vox Sang; 2000; 78 Suppl 2():163-6. PubMed ID: 11203397
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
9. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
10. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
[TBL] [Abstract][Full Text] [Related]
11. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
12. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes.
Shander A; Fink A; Javidroozi M; Erhard J; Farmer SL; Corwin H; Goodnough LT; Hofmann A; Isbister J; Ozawa S; Spahn DR;
Transfus Med Rev; 2011 Jul; 25(3):232-246.e53. PubMed ID: 21498040
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of ABO-incompatible RBC transfusions.
Janatpour KA; Kalmin ND; Jensen HM; Holland PV
Am J Clin Pathol; 2008 Feb; 129(2):276-81. PubMed ID: 18208808
[TBL] [Abstract][Full Text] [Related]
14. Practice and costs of red blood cell (RBC) transfusion in an oncological unit.
Norum J; Moen MA
Anticancer Res; 2008; 28(1B):459-64. PubMed ID: 18383885
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study evaluating single-unit red blood cell transfusions in reducing allogeneic blood exposure.
Ma M; Eckert K; Ralley F; Chin-Yee I
Transfus Med; 2005 Aug; 15(4):307-12. PubMed ID: 16101808
[TBL] [Abstract][Full Text] [Related]
16. Coagulation defects do not predict blood product requirements during liver transplantation.
Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
[TBL] [Abstract][Full Text] [Related]
17. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.
de Boer MT; Christensen MC; Asmussen M; van der Hilst CS; Hendriks HG; Slooff MJ; Porte RJ
Anesth Analg; 2008 Jan; 106(1):32-44, table of contents. PubMed ID: 18165548
[TBL] [Abstract][Full Text] [Related]
18. Restrictive red blood cell transfusion strategies in critical care: does one size really fit all?
Nichol AD
Crit Care Resusc; 2008 Dec; 10(4):323-7. PubMed ID: 19049485
[TBL] [Abstract][Full Text] [Related]
19. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
[TBL] [Abstract][Full Text] [Related]
20. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
Glenngård AH; Persson U; Söderman C
Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
